Flagship Pioneering’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
2017
Q1
$11.8M Hold
2016
Q4
$14.2M Sell
2016
Q3
$23.5M Buy